Navigation Links
MMJ BioPharma Cultivation Announces Plans To Grow DEA Licensed Cannabis In Partnership With Native American Tribe
Date:6/13/2019

MMJ BioPharma Cultivation, a premier medical cannabis cultivation and research company today announced that it has signed a memorandum of understanding (MOU) with MMJ International Holdings to grow cannabis and supply active pharmaceutical ingredients (API) for its drug product MMJ-001 and MMJ-002.

MMJ BioPharma Cultivation will be supplying MMJIH with extracts from the marijuana plant to support its investigational new drug (IND) filings with the FDA for Multiple Sclerosis and Huntington’s disease. It will also plan to meet the growing demand from hospitals, researchers, and scientist for their FDA/DEA approved clinical trials.

MMJ BioPharma Cultivation has applied for a DEA Schedule-I Bulk Manufacturer license to cultivate cannabis plants for this purpose. MMJ BioPharma Cultivation will facilitate a process of scientific drug development and discovery governed by FDA protocol development processes and DEA regulatory manufacturing guidelines.

To further meet the statutory requirements of the “public benefit” MMJ BioPharma Cultivation has entered into an agreement with a US Native Indian Tribe to perform its development activities. MMJ BioPharma Cultivation is planning a phased development program on Native American Tribal Trust lands of approximately 1 million square feet with a state of the art extraction analytics lab to meet DEA approved researchers needs. MMJ BioPharma Cultivation will be employing tribal members in its development and cultivation program.

Dr. Elio Mariani, a senior executive of the company and big pharma veteran stated “we are looking forward to our collaboration with the tribe in unlocking the potential of cannabinoid medicines to address serious medical conditions. Our efforts will be guided by the FDA and DEA as we strive to produce the highest pharma grade plants and extracts for clinical research.”

Read the full story at https://www.prweb.com/releases/mmj_biopharma_cultivation_announces_plans_to_grow_dea_licensed_cannabis_in_partnership_with_native_american_tribe/prweb16347165.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related medicine news :

1. Biopharmaceutical Success Depends on Delivery, Fueling $7.8 BN Market: Report
2. Catalent Wins Prestigious Clinical Supply Chain Excellence Award at BioPharma Asia Convention
3. Accelerated Biopharmaceutical Development through Strategic Analytical Partnerships to be Discussed by Catalent Expert at Upcoming WCBP Conference
4. VetStem Biopharma Begins Enrollment in Pivotal FDA Clinical Study of Osteoarthritis in Dogs
5. Beckman Coulter Webinar Helps You Skirt the Pitfalls When Automating Cell Viability Counting for Biopharma QC
6. U.S. Ranks 1st in How Its National Policies Impact Global Biopharma Innovation, ITIF Finds in New Analysis Marking World Health Day
7. Reliable Biopharmaceutical Announces New Investor and Chairman
8. Optimizing Early Stage Drug Development and Best Practices in Clinical Trial Supply Management to be Presented by Catalent Experts at Biopharma Asia in Singapore
9. FDAnews Announces — The Biopharmaceutical Facility of the Future: To 2025 and Beyond Webinar, Sept. 29, 2015
10. Dr. Kevin Sadati Discusses the Impact of Allergan Acquiring KYTHERA Biopharmaceuticals
11. Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/17/2019)... ... July 17, 2019 , ... Guruji Mahendra Trivedi, founder ... on today’s issues affecting humanity at practical and spiritual levels. Guruji Mahendra Trivedi ... July 20, 2019. , Guruji Mahendra Trivedi offers these powerful workshops to deepen ...
(Date:7/17/2019)... ... ... It took just several small incisions by St. Luke's University Health ... nerves under Amber Walck’s scalp, and suddenly her two-year agony with migraines was history. ... headaches began without warning. About 39 million Americans suffer from migraines that range ...
(Date:7/17/2019)... ... July 17, 2019 , ... A new study led by ... the American Medical Association (JAMA), shows for the first time that New York’s ... state. Sepsis is the body’s extreme response to infection. It kills more than 275,000 ...
(Date:7/13/2019)... ... 14, 2019 , ... Dr. Rupa Jolly, dentist and wife of Dr. Tarun ... of Most Influential New Orleanians in 2019. She joins more than 20 other locals ... made an impact on the New Orleans community. , Combining their backgrounds in science ...
(Date:7/13/2019)... ... July 12, 2019 , ... China Focus ... Center , sponsored by Hangzhou Investment Promotion Bureau, Fox Rothschild LLP, MORE Health ... The conference attracted Fosun Pharmaceuticals, WuXi Biologics, Kelun Pharmaceutical, Harbin Pharmaceuticals, Fountain Medical, ...
Breaking Medicine News(10 mins):
(Date:7/19/2019)... SAN FRANCISCO (PRWEB) , ... July 19, 2019 ... ... Blumenthal Nordrehaug Bhowmik De Blouw LLP, lodged a putative class action lawsuit ... California with the legally required thirty minute uninterrupted meal periods and rest periods. ...
(Date:7/18/2019)... WEST GROVE, Pa. (PRWEB) , ... July 18, 2019 , ... ... with the Bushel and Berry Collection of homegrown edible berry bushes. , ... bring beauty and healthy, delicious fruit to any garden or on the patio in ...
(Date:7/17/2019)... ... , ... Princeton, New Jersey – Supply Chain Wizard , a leader ... a 2019 ‘Cool Vendor’ by Gartner, Inc. in Supply Chain Execution Technologies. , According ... on two things. First, given the clear preferences of supply chain users, we looked ...
Breaking Medicine Technology: